HMCEF is a P-selectin inhibitor. It acts by intercalating into calf thymus DNA, cutting off DNA pBR22 and inhibiting the proliferation of cancer cells. References: Wu J, Zhao M, Wang Y, Wang Y, Zhu H, Zhao S, Gui L, Zhang X, Peng S. N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation. Drug Des Devel Ther. 2017 Jan 17;1225-239. doi: 10.2147/DDDT.S123919. eCollection 2017. PubMed PMID: 28176928; PubMed Central PMCID: PMC5265142.

纯度：≥98%

CAS：2002363-68-8